文献速递胰腺与胆道疾病消化内镜

胰腺囊性病变EUS引导经针活检的临床结局与不良事件风险分层

Evaluating clinical outcomes and adverse events: risk stratification of endoscopic ultrasound-guided through-the-needle biopsy for pancreatic cyst in a large cohort.
PubMed 文献 · Gastrointest Endosc · 2026-01-29

这项回顾性研究纳入301例接受EUS-TTNB的胰腺囊性病变患者,诊断充分性达80.3%,手术切除病例组织学一致率87.5%,16.3%病例诊断和治疗发生改变。不良事件发生率20.9%,急性胰腺炎最常见(15%)。多因素分析显示IPMN是AE危险因素,完全抽吸囊液为保护因素,RPA模型将风险分为低、中、高三层。

要点

  • EUS-TTNB诊断充分性高(80.3%),可改变16.3%病例的诊断与治疗决策。
  • 不良事件率20.9%,急性胰腺炎最常见(15%);IPMN增加AE风险,完全抽吸囊液降低风险。
  • RPA风险分层:低危AE率11.9%,中危20.6%,高危37.0%,有助于患者选择。

核心结论

  • EUS-TTNB在修正诊断和影响治疗决策方面具有显著临床价值,但不良事件风险较高。
  • 应用基于预测因素的风险分层模型并谨慎选择患者,可提升其临床效用。

研究设计与样本

  • 回顾性研究,纳入韩国首尔Asan Medical Center接受EUS-TTNB的301例胰腺囊性病变患者。
  • 采用置换检验准确度和递归分割分析(RPA)进行风险评估。

主要发现

  • 诊断充分性80.3%(241/301),手术切除病例组织学一致率87.5%(42/48)。
  • 16.3%(49/301)病例诊断和治疗发生改变。
  • 不良事件发生率20.9%,急性胰腺炎最常见(15%,45/301)。
  • RPA风险分层:低危AE率11.9%(非IPMN且完全抽吸或≥4次经针活检),高危37.0%(IPMN且年龄≥70岁或未完全抽吸),中危20.6%(未归类为低或高危)。

关键数值与推荐

  • 诊断充分性80.3%(241/301),组织学一致率87.5%(42/48),诊断治疗改变率16.3%(49/301)。
  • AE发生率20.9%,急性胰腺炎15%(45/301)。

临床怎么用

  • 对胰腺囊性病变患者行EUS-TTNB前,应评估IPMN状态、年龄及能否完全抽吸囊液以进行风险分层。
  • 高危患者(IPMN且年龄≥70岁或未完全抽吸)AE风险达37.0%,需谨慎权衡获益与风险。
  • 低危患者(非IPMN且完全抽吸或≥4次经针活检)AE风险11.9%,可考虑积极活检以指导治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Despite concerns regarding its safety and the incidence of adverse events (AEs), EUS-guided through-the-needle biopsy (EUS-TTNB) has emerged as a promising diagnostic tool. This study evaluated the clinical effectiveness of EUS-TTNB, assessed procedural AEs, and categorized risks based on predictive factors using recursive partitioning analysis (RPA). METHODS: This retrospective study included 301 patients who underwent EUS-TTNB at Asan Medical Center, Seoul, South Korea, using permutation-based accuracy and RPA. RESULTS: EUS-TTNB exhibited high diagnostic adequacy (80.3%, 241/301), showed strong histologic concordance among surgically resected cases (87.5%, 42/48), and led to changes in diagnosis and management in 16.3% of cases (49/301). AEs occurred in 20.9% of cases, with acute pancreatitis being the most common (15%, 45/301). Multivariable analysis identified intraductal papillary mucinous neoplasm (IPMN) (odds ratio [OR], 2.24; 95% CI, 1.26-3.98; P = .006) and complete cyst aspiration (OR, 0.50; 95% CI, 0.28-0.90; P = .02) as significant risk factors for AEs. In RPA, a random forest model and permutation-based accuracy were used to create 3 risk categories: low (AE rate: 11.9%, non-IPMN with complete cyst aspiration or ≥4 through-the-needle biopsies); high (AE rate: 37.0%, IPMN with age ≥70 or without complete cyst aspiration); and moderate (AE rate: 20.6%, not classified as low or high risk). CONCLUSIONS: EUS-TTNB demonstrated notable clinical utility in revising diagnoses and influencing therapeutic decisions but poses a considerable risk of AEs. By applying this risk categorization model with careful consideration and patient selection, its clinical utility may be enhanced.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Lee HS, Song TJ, Oh D, et al. Evaluating clinical outcomes and adverse events: risk stratification of endoscopic ultrasound-guided through-the-needle biopsy for pancreatic cyst in a large cohort. Gastrointest Endosc. 2026. PMID: 41620141. doi:10.1016/j.gie.2026.01.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。